Association between urinary arsenic species and IL-17A cytokine production stratified by low and high Vitamin D levels. by Faruque Parvez (13136)

Subjects:

Introgression decreases allelic shuffling. by Enrique J. Schwarzkopf (6579275)

The p53-MDM2 interaction was monitored via fluorescence spectroscopy. by Deepu Dowarha (5673440)

The p53-Peptide 1 interaction was monitored via fluorescence spectroscopy. by Deepu Dowarha (5673440)

Comparison of the decrease of CFU in CSF and blood between treatment groups within the first 6 h after treatment. by Luca G. Valente (12463057)

MST1 upregulates CD36 expression via PPARγ. by Jianyang Li (461703)

Green Hydrogen Economy: Scenarios versus Technologies by Hua Fan (495346)

“…Scenarios employing off-grid renewable energy without battery storage, coupled with low-capital-expenditure electrolyzers and optimized maintenance, offer the greatest cost benefits. This framework provides a basis for green hydrogen system design, highlighting the critical role of operational optimization in accelerating cost-effective deployment.…”

Adjusted^a mean decrease in days elapsed in the cascade of HCC care post-intervention. by Yapei Zhang (6416108)

Silencing of TET3 acted to decrease mitochondrial respiration in N2A cells. by Valeria Leon Kropf (17797623)

Pirk-like knockdown decreased egg production. by Mao Wang (115790)

SHAP dependence plots for four most influential decreasing gait parameters via RF model. by Mohammad Pourmahmood Aghababa (18290996)

Development of a Highly Efficient NIR-II Phototherapeutic Agent for Fluorescence Imaging-Guided Synergistic PTT/PDT/Chemotherapy of Colorectal Cancer by Ji Liu (110659)

“…To decrease thermal resistance during phototherapy, IRF and evodiamine (EVO) were loaded onto hyaluronic acid (HA)-modified nanoparticles, creating a multifunctional nanoplatform termed EVO/IRF@HA NPs. …”

Image_2_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

Image_1_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

Image_3_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

Inhibition of CREB via 666–15 in the presence of PMA resulted in a further decrease in <i>GRK6</i> promoter activity. by Maike Stegen (8578665)

Image_14_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

Image_13_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

Image_4_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

Presentation_1_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.pdf by Rohit Moudgil (540119)